PWP vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

PWP

49.4
AI Score
VS
HIVE Wins

HIVE

57.7
AI Score

Investment Advisor Scores

PWP

49score
Recommendation
HOLD

HIVE

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PWP HIVE Winner
Forward P/E 0 62.8931 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.8% 73.5% HIVE
Earnings Growth 52.2% -99.9% PWP
Tradestie Score 49.4/100 57.7/100 HIVE
Profit Margin 3.2% -98.5% PWP
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PWP 1M: -6.5% · 3M: -16.6% HIVE 1M: -42.7% · 3M: -36.2%

Current Technical Phase

PWP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.0%), weak momentum, RSI 33

RSI (14): 32.9 · Price: $12.47

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.1%), weak momentum, RSI 26

RSI (14): 25.6 · Price: $2.03

Fundamentals Snapshot

Metric PWP HIVE
Market Cap — —
Forward P/E 9.3 -4.0
Trailing P/E 48.9 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin 1.0% 0.4%
Operating Margin 0.1% -0.6%
EPS 0.26 -1.32
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.